HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Klaudia Puckmair Selected Research

Ovarian Neoplasms (Ovarian Cancer)

4/2005An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Klaudia Puckmair Research Topics

Disease

3Neoplasms (Cancer)
11/2007 - 04/2005
1Breast Neoplasms (Breast Cancer)
11/2007
1Ovarian Neoplasms (Ovarian Cancer)
04/2005
1Carcinoma (Carcinomatosis)
04/2005

Drug/Important Bio-Agent (IBA)

3RetinoidsIBA
11/2007 - 04/2005
3retinoic acid receptor betaIBA
11/2007 - 04/2005
2ErbB Receptors (EGF Receptor)IBA
11/2007 - 04/2005
24- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazolineIBA
11/2007 - 04/2005
2DNA (Deoxyribonucleic Acid)IBA
11/2007 - 04/2005
1Protein Isoforms (Isoforms)IBA
11/2007
1Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2005

Therapy/Procedure

1Therapeutics
04/2005